Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y8RM
|
||||
| Former ID |
DNC003238
|
||||
| Drug Name |
(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H17O3P
|
||||
| Canonical SMILES |
CC(C(C)(C)C)OP(=O)(C)O
|
||||
| InChI |
1S/C7H17O3P/c1-6(7(2,3)4)10-11(5,8)9/h6H,1-5H3,(H,8,9)/t6-/m0/s1
|
||||
| InChIKey |
BLALDUPQYCGKAG-LURJTMIESA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Lipoprotein-associated phospholipase A2 | Target Info | Inhibitor | [1] | |
| Liver carboxylesterase | Target Info | Inhibitor | [1] | ||
| KEGG Pathway | Ether lipid metabolism | ||||
| Metabolic pathways | |||||
| Biosynthesis of antibioticshsa00983:Drug metabolism - other enzymes | |||||
| Pathway Interaction Database | Lissencephaly gene (LIS1) in neuronal migration and developmente2f_pathway:E2F transcription factor network | ||||
| WikiPathways | IL1 and megakaryotyces in obesity | ||||
| Synthesis, Secretion, and Deacylation of GhrelinWP2884:NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Heroin metabolism | |||||
| Irinotecan Pathway | |||||
| Fluoropyrimidine Activity | |||||
| Phase I biotransformations, non P450 | |||||
| References | |||||
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.